Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
9.12
+0.46 (5.31%)
Feb 27, 2026, 4:00 PM EST - Market closed
Passage Bio Employees
Passage Bio had 60 employees as of December 31, 2024. The number of employees increased by 2 or 3.45% compared to the previous year.
Employees
60
Change (1Y)
2
Growth (1Y)
3.45%
Revenue / Employee
n/a
Profits / Employee
-$754,400
Market Cap
28.99M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Kyntra Bio | 225 |
| IGC Pharma | 70 |
| Werewolf Therapeutics | 39 |
| Lantern Pharma | 24 |
| AN2 Therapeutics | 22 |
| Tempest Therapeutics | 21 |
| NeuroSense Therapeutics | 17 |
| BriaCell Therapeutics | 16 |
PASG News
- 9 days ago - Passage Bio to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - Passage Bio Reports Third Quarter 2025 Financial Results and Provides Recent Business Highlights - GlobeNewsWire
- 4 months ago - Passage Bio to Present at Guggenheim Securities 2nd Annual Healthcare Innovation Conference - GlobeNewsWire
- 4 months ago - Passage Bio to Participate in Chardan's 9th Annual Genetic Medicines Conference - GlobeNewsWire
- 6 months ago - Passage Bio to Participate in H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 7 months ago - Passage Bio Reports Second Quarter 2025 Financial Results and Provides Recent Business Highlights - GlobeNewsWire
- 8 months ago - Passage Bio Announces 1-for-20 Reverse Stock Split - GlobeNewsWire
- 8 months ago - Passage Bio Reports Updated Interim Data from upliFT-D Study and Provides Program Update - GlobeNewsWire